Pmda - Pharmaceuticals and Medical Devices Agency
Menu
Close

Post-marketing Safety Measures

Revisions of PRECAUTIONS (FY2023)

Posted date Nonproprietary name
(Click on each regenerative medical product name for more information
[only in Japanese])
Detailed information on revisions of PRECAUTIONS (from MHLW) Summary of investigation results (from PMDA)
March 28, 2024 Axicabtagene ciloleucel PDF形式 PDF形式
Idecabtagene vicleucel
Tisagenlecleucel
Lisocabtagene maraleucel
January 10, 2024 Ciltacabtagene autoleucel PDF形式 PDF形式
August 29, 2023 Axicabtagene ciloleucel PDF形式 PDF形式
Idecabtagene vicleucel
Ciltacabtagene autoleucel
Tisagenlecleucel
Lisocabtagene maraleucel